Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Anna Dimberg
The kinase inhibitor dabrafenib halts progression of cerebral cavernous malformations in a BRAF-independent manner
Reference #1 Abstract Supplementary Materials REFERENCES AND NOTES eLetters (0) Information & Authors Metrics & Citations Check Access References Figures Tables Media Share This article has 0 eLetter . Abstract Cerebral cavernous malformations (CCMs) constitute the second most common type of intracranial vascular malformations.
Podoplanin-defined tumour plasticity and CCR7-mediated lymphatic metastasis in triple-negative breast cancer
Abstract Lymphatic metastasis is strongly associated with poor prognosis. Although the chemokine receptor CCR7 is a well-established promoter of lymphatic dissemination, its prognostic relevance remains weak. We show that tumour cell plasticity, defined by podoplanin (PDPN)-expression and promoted by hypoxia, intersects with CCR7 function in triple-negative breast cancer (TNBC). In vivo and in vitro studies using a CCR7-expressing TNBC mouse model were combined with transcriptomic profiling.
Shining the LIGHT on Glioblastoma : Understanding and exploiting vascular and immune co-targeting
Nyckelord: MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; Tertiary lymphoid structure; high endothelial venule; glioblastoma; glioma; immunotherapy; Medicinsk vetenskap; Medical Science; Sammanfattning: Patients diagnosed with glioblastoma (GBM) have an extremely poor prognosis despite extensive research in the recent years, with a five-year overall survival of only 7%.
KRIT1 heterozygous mutations are sufficient to induce a pathological phenotype in patient-derived iPSC models of cerebral cavernous malformation
|
Keywords BBB CCM KRIT1 vascular malformations iPSCs vascularized organoids endothelial cells Research topic(s) CP: Stem cell research Introduction Brain functionality is extensively supported by an intrinsic network of a highly specialized vasculature, the blood-brain barrier (BBB).
By Maximiliano Arce, Fan Yang, Favour C. Onyeogaziri, Dario Ronchi, Nora Noll, Roberta Lugano, Mark Richards, Elisa Scola, Monica Corada, Francesca Lazzaroni, Niklas Dahl, Mika Niemelä, Behnam Rezai Jahromi, Anna Dimberg, Roberto A. Latini, Peetra U. Magnusson, Iza Erzar, Neeharika Senthilkumar, Frida C. Ahlstrand, Linda Meggiolaro, Silvia Lanfraconi
|
Cell Reports
Verified
To a Radiant Future and Beyond : Improving Radiotherapy of Neuroblastoma
Nyckelord: MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; Cancer; targeted radionuclide therapy; external beam radiotherapy; radiosensitization; neuroblastoma; p53; MDM2 MDM4 inhibition; HSP90; CD44v6; antibodies; Sammanfattning: Neuroblastoma is a pediatric cancer with a five-year survival rate of merely 50% for high-risk cases.
Vascular characterization reveals immunomodulatory targets for brain metastases
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.
Vascular characterization reveals immunomodulatory targets for brain metastases
The brain tumor-associated vasculature is a key component of the tumor microenvironment in brain metastasis, protecting cancer cells from immune attack and interfering with the delivery of therapeutic agents into the brain. In this study, Bejarano et al. unravel the vascular heterogeneity in human BrM and further construct a preclinical platform to design novel vascular-targeted therapeutic strategies for the treatment of these aggressive tumors.
Author Correction: A method for Boolean analysis of protein interactions at a molecular level - Nature Communications
Correction to: Nature Communications https://doi.org/10.1038/s41467-022-32395-w, published online 13 August 2022 The original version of this Article contained an error in Table 1.
Complementarity-determining region clustering may cause CAR-T cell dysfunction - Nature Communications
Abstract Chimeric antigen receptor (CAR)-T cell therapy is rapidly advancing as cancer treatment, however, designing an optimal CAR remains challenging. A single-chain variable fragment (scFv) is generally used as CAR targeting moiety, wherein the complementarity-determining regions (CDRs) define its specificity. We report here that the CDR loops can cause CAR clustering, leading to antigen-independent tonic signalling and subsequent CAR-T cell dysfunction.
A method for Boolean analysis of protein interactions at a molecular level - Nature Communications
Abstract Determining the levels of protein–protein interactions is essential for the analysis of signaling within the cell, characterization of mutation effects, protein function and activation in health and disease, among others. Herein, we describe MolBoolean – a method to detect interactions between endogenous proteins in various subcellular compartments, utilizing antibody-DNA conjugates for identification and signal amplification.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Anna
Contact Anna, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack